D
CureVac N.V. CVAC
$5.16 $0.050.98% NASDAQ
Recommendation
Prev Close
$5.11
Volume
1,477,185
Avg Vol (90D)
776,007
Market Cap
$1.15B
Dividend & Yield
--
52-Week Range
$2.48 - $5.72
P/E (TTM)
--
EPS (TTM)
-$0.54
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
BioNTech Achieves Minimum Condition in CureVac Exchange Offer
12/3/2025 - GuruFocus
BioNTech (BNTX) Advances with CureVac Acquisition
12/3/2025 - GuruFocus
BioNTech achieves minimum condition in CureVac exchange offer
12/3/2025 - The Fly
BioNTech Achieves Minimum Condition in CureVac Exchange Offer
12/3/2025 - Globe Newswire
Can New Board Leadership at CureVac (CVAC) Shift the Narrative After Recent Earnings Decline?
12/1/2025 - Simply Wall St
The volume for CureVac stock increased for one day, resulting in a record-breaking daily growth of 663% of the 65-Day Volume Moving Average
11/29/2025 - Tickeron - Stocks
Carlson Capital L.P. Makes New Investment in CureVac N.V. $CVAC
11/28/2025 - MarketBeat
CureVac N.V. (CVAC) Shareholder/Analyst Call Prepared Remarks Transcript
11/28/2025 - SeekingAlpha
CureVac N.V. (CVAC) Shareholder/Analyst Call Prepared Remarks Transcript
11/28/2025 - Seeking Alpha: Transcripts
CureVac (NASDAQ:CVAC) Sees Large Volume Increase - Here's What Happened
11/27/2025 - MarketBeat
CureVac (CVAC, $5.48) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 26, 2025
11/27/2025 - Tickeron - Stocks
BioNTech Advances with CureVac Exchange Offer Approval
11/26/2025 - TipRanks Financial Blog
CureVac Shareholders Approve BioNTech Exchange Offer
11/26/2025 - TipRanks Financial Blog
BioNTech (BNTX) Moves Forward with CureVac Acquisition
11/26/2025 - GuruFocus
BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, ...
11/26/2025 - GuruFocus
BioNTech (BNTX) Advances with Exchange Offer for CureVac Shares
11/26/2025 - GuruFocus
BioNTech's exchange offer for German mRNA vaccine peer CureVac set to expire Dec. 3
11/26/2025 - Seeking Alpha - Healthcare
BioNTech shares update on exchange offer for CureVac shares
11/26/2025 - The Fly
BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration
11/26/2025 - Globe Newswire
CureVac Announces Voting Results of Extraordinary General Meeting
11/26/2025 - GuruFocus
CureVac Announces Voting Results of Extraordinary General Meeting
11/26/2025 - ACCESS Newswire
CureVac (NASDAQ:CVAC) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS
11/25/2025 - MarketBeat
CureVac (CVAC, $5.11) RSI Indicator left the oversold zone on November 24, 2025
11/25/2025 - Tickeron - Stocks
The volume for CureVac stock increased for three consecutive days, resulting in a record-breaking daily growth of 139% of the 65-Day Volume Moving Average
11/25/2025 - Tickeron - Stocks
Company News for Nov 25, 2025
11/25/2025 - Zacks Investment Research
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
$809.02M
Total Debt (Q)
$42.32M
Total Liabilities (Q)
$120.39M
Book Value Per Share (Q)
$3.06
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Friday, August 15, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Apr 6 and 10 (est)
Price History
Loading...
Beta
1.01
7-Day Total Return
2.58%
30-Day Total Return
-3.91%
60-Day Total Return
-4.09%
90-Day Total Return
-4.80%
Year to Date Total Return
49.57%
1-Year Total Return
81.05%
2-Year Total Return
-7.19%
3-Year Total Return
-32.11%
5-Year Total Return
-94.97%
52-week Low
Apr 07, 2025 - $2.48
52-week High
Jun 12, 2025 - $5.72
Valuation
Market Cap
$1.15B - Small Cap
Enterprise Value
$703.63M
Price/Sales (TTM)
505.94
Price/Book (Q)
1.67
Dividends and Shares
Shares Outstanding
232.35
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.curevac.com
Phone Number
49 7071 9883 0
Address
Friedrich-Miescher-Strasse 15
Tübingen, 72076
Country
Germany
Year Founded
2000
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). The company’s portfolio includes clinical and... more
NASDAQ 12/03/2025 4:00PM Eastern Quotes delayed